Scrip Asks… What Does 2025 Hold For Biopharma? Part 1: The State Of The Biopharma Industry
Rigor Needed To Harness Innovation For Growth
More than 40 industry executives shared their views on where the biopharma industry stands as it enters the new year. Innovation remains the sector’s driving force, but after two years of capital constraint, due diligence is key.
